Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)

ClinicalTrials.gov ID: NCT01157078

Public ClinicalTrials.gov record NCT01157078. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 4:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Phase III Efficacy and Safety Study of TC-5214 (S-mecamylamine) in Flexible Doses as an Adjunct to an Antidepressant in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if TC-5214 or placebo (a tablet that looks like medicine tablet or capsule, but contains no active medicine) is safe and effective when taken together with another antidepressant.

Study identification

NCT ID
NCT01157078
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
319 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2010 (Type not available)
Primary completion
Nov 2011 (Actual)
Completion
Nov 2011 (Actual)
Last update posted
Apr 11, 2014

2010 – 2011

United States locations

U.S. sites
37
U.S. states
19
U.S. cities
37
Facility City State ZIP Site status
Research Site Tuscaloosa Alabama — —
Research Site Tucson Arizona — —
Research Site Little Rock Arkansas — —
Research Site Chino California — —
Research Site Costa Mesa California — —
Research Site Encino California — —
Research Site Escondido California — —
Research Site Los Alamitos California — —
Research Site Oceanside California — —
Research Site Pico Rivera California — —
Research Site San Diego California — —
Research Site Torrance California — —
Research Site Hamden Connecticut — —
Research Site Coral Springs Florida — —
Research Site Jacksonville Florida — —
Research Site Orange City Florida — —
Research Site Orlando Florida — —
Research Site Tampa Florida — —
Research Site Chicago Illinois — —
Research Site Prairie Village Kansas — —
Research Site Florence Kentucky — —
Research Site Shreveport Louisiana — —
Research Site St Louis Missouri — —
Research Site New York New York — —
Research Site Rochester New York — —
Research Site Staten Island New York — —
Research Site Cincinnati Ohio — —
Research Site Dayton Ohio — —
Research Site Middleburg Heights Ohio — —
Research Site Portland Oregon — —
Research Site Salem Oregon — —
Research Site Norristown Pennsylvania — —
Research Site Charleston South Carolina — —
Research Site Dallas Texas — —
Research Site Houston Texas — —
Research Site Woodstock Vermont — —
Research Site Seattle Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01157078, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 11, 2014 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01157078 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →